Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib in BRAF+ Melanoma
NCT01037127Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of trametinib in cutaneous melanoma (CM), sponsored by GSK. Started Nov 2009; status: completed.
02
Drugs
trametinib
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT01037127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037127.